{"id":8346,"date":"2013-07-30T16:16:17","date_gmt":"2013-07-30T16:16:17","guid":{"rendered":""},"modified":"2013-07-30T16:16:17","modified_gmt":"2013-07-30T16:16:17","slug":"omega-3-riebalu-rugsciu-poveikis-sirdies-ir-kraujagysliu-ligoms","status":"publish","type":"post","link":"https:\/\/www.pasveik.lt\/lt\/naujausi-medicinos-straipsniai\/omega-3-riebalu-rugsciu-poveikis-sirdies-ir-kraujagysliu-ligoms\/8346\/","title":{"rendered":"Omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 poveikis \u0161irdies ir kraujagysli\u0173 ligoms"},"content":{"rendered":"<p><!--[if gte mso 9]><xml>\n <o:OfficeDocumentSettings>\n  <o:AllowPNG\/>\n  <o:TargetScreenSize>1024x768<\/o:TargetScreenSize>\n <\/o:OfficeDocumentSettings>\n<\/xml><![endif]--><\/p>\n<p><!--[if gte mso 9]><xml>\n <w:WordDocument>\n  <w:View>Normal<\/w:View>\n  <w:Zoom>0<\/w:Zoom>\n  <w:HyphenationZone>19<\/w:HyphenationZone>\n  <w:Compatibility>\n   <w:BreakWrappedTables\/>\n   <w:SnapToGridInCell\/>\n   <w:WrapTextWithPunct\/>\n   <w:UseAsianBreakRules\/>\n  <\/w:Compatibility>\n <\/w:WordDocument>\n<\/xml><![endif]--><!--[if !mso]><object \nclassid=\"clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D\" id=ieooui><\/object>\n\n\n<style>\nst1\\:*{behavior:url(#ieooui) }\n<\/style>\n\n\n<![endif]--><!--[if gte mso 10]>\n\n\n<style>\n \/* Style Definitions *\/\n table.MsoNormalTable\n\t{mso-style-name:\"Table Normal\";\n\tmso-tstyle-rowband-size:0;\n\tmso-tstyle-colband-size:0;\n\tmso-style-noshow:yes;\n\tmso-style-parent:\"\";\n\tmso-padding-alt:0cm 5.4pt 0cm 5.4pt;\n\tmso-para-margin:0cm;\n\tmso-para-margin-bottom:.0001pt;\n\tmso-pagination:widow-orphan;\n\tfont-size:10.0pt;\n\tfont-family:\"Times New Roman\";}\n<\/style>\n\n\n<![endif]--><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">\u0160irdies ir kraujagysli\u0173 ligos yra pagrindin\u0117 Europos moter\u0173 ir vyr\u0173 mirties prie\u017eastis. D\u0117l \u0161i\u0173 lig\u0173 53 Pasaulio sveikatos organizacijose Europos regiono \u0161alyse mir\u0161ta 4,35 mln., o Europos S\u0105jungos \u0161alyse \u2013 1,9 mln. \u017emoni\u0173. Kas antras Europos regiono pilietis mir\u0161ta nuo \u0161irdies ir kraujagysli\u0173 lig\u0173 \u2013 nuo j\u0173 mir\u0161ta daugiau \u017emoni\u0173 nei nuo vis\u0173 v\u0117\u017eio form\u0173 kartu pa\u0117mus. Kas lemia tok\u012f didel\u012f mirtingum\u0105? Svarbiausi \u0161irdies ir kraujagysli\u0173 lig\u0173 rizikos veiksniai yra r\u016bkymas, nesaikingas alkoholio vartojimas, netaisyklinga mityba, kai valgoma daug riebaus, s\u016braus bei a\u0161traus maisto. \u012etakos turi ir cukrinis diabetas, <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/nutukimas\/4355\">nutukimas<\/a>, ma\u017eas fizinis aktyvumas, emocin\u0117 \u012ftampa, paveld\u0117jimas. Visa tai skatina vystytis l\u0117tin\u0119 arterij\u0173 lig\u0105 \u2013 ateroskleroz\u0119. <\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Terminas \u201e<a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">ateroskleroz\u0117<\/a>\u201c yra kil\u0119s i\u0161 graik\u0173 kilm\u0117s \u017eod\u017eio <em style=\"mso-bidi-font-style: normal;\">atherosclerosis<\/em>: <em style=\"mso-bidi-font-style: normal;\">ather<\/em> \u2013 ko\u0161el\u0117 ir <em style=\"mso-bidi-font-style: normal;\">sclero<\/em> \u2013 kietas. <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">Ateroskleroz\u0117<\/a> yra l\u0117tin\u0117 arterij\u0173 sieneli\u0173 liga, kuri skatina aterosklerozini\u0173 plok\u0161teli\u0173 (medicini\u0161kai vadinam\u0173 ateromomis) susidarym\u0105. Jos susidaro vidiniame arterijos sluoksnyje i\u0161 riebal\u0173, cholesterolio, l\u0105steli\u0173 apykaitos atliek\u0173, kalcio ir kit\u0173 med\u017eiag\u0173. Liaudi\u0161kai <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">ateroskleroz\u0117<\/a> vadinama \u201ekraujagysli\u0173 kalk\u0117jimu\u201c. Ateroskleroziniai poky\u010diai arterijose atsiranda dar jaunyst\u0117je, o b\u0117gant metams progresuoja. Jau dvide\u0161imtme\u010diams randami pakitimai arterij\u0173 sienel\u0117se (17 proc.), o net 70 proc. keturiasde\u0161imtme\u010di\u0173 kraujagysl\u0117s yra jau pakitusios. I\u0161sivys\u010diusiose Vakar\u0173 \u0161alyse daugiau kaip 50 proc. mir\u010di\u0173 sudaro ligos, kurias sukelia <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">ateroskleroz\u0117<\/a>. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Kaip i\u0161sivysto <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">ateroskleroz\u0117<\/a><\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Arterijos sienel\u0117 susideda i\u0161 trij\u0173 sluoksni\u0173: i\u0161orinio, vidurinio ir vidinio. Kai padid\u0117ja riebal\u0173, ypa\u010d cholesterolio kiekis kraujyje ar veikiant cigare\u010di\u0173 d\u016bm\u0173 med\u017eiagoms, padid\u0117jus kraujo spaudimui ir veikiant kitiems rizikos veiksniams, yra su\u017ealojamas vidinis arterijos sluoksnis ir susiformuoja aterosklerozin\u0117 plok\u0161tel\u0117. Toje vietoje kaupiasi riebalai ir kalcis, tod\u0117l susidariusios aterosklerozin\u0117s plok\u0161tel\u0117s sukiet\u0117ja. V\u0117liau pa\u017eeidimas did\u0117ja ir vis labiau siaurina arterij\u0105 ir trukdo tek\u0117ti kraujui. Vidinis arterijos sluoksnis labai i\u0161plon\u0117ja ir i\u0161sigaubia \u012f kraujagysl\u0117s spind\u012f. Tokios plok\u0161tel\u0117s gali ply\u0161ti, ply\u0161imo vietoje formuojasi trombas, kuris gali u\u017ekim\u0161ti kraujagysl\u0119 arba atitr\u016bkti ir nukeliauti \u012f kitas kraujagysles, taip sukeldamas miokardo infarkt\u0105, galvos smegen\u0173 insult\u0105, u\u017ekim\u0161ti inkst\u0173 ar \u017earnyno kraujagysles.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Veiksniai, skatinantys vystytis ateroskleroz\u0119<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\"><a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">Ateroskleroz\u0117<\/a> vystosi \u017emogui senstant, ta\u010diau yra tam tikri rizikos veiksniai, kurie sukelia ar spartina jos vystym\u0105si:<\/span><\/em><\/p>\n<ul style=\"margin-top: 0cm;\" type=\"disc\">\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">R\u016bkymas. R\u016bkant toksin\u0117s med\u017eiagos pa\u017eeid\u017eia arterij\u0173 sienel\u0119. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Padid\u0117j\u0119s arterinis kraujo spaudimas. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Nekoreguotas <a href=\"http:\/\/www.sos03.lt\/Ligos\/Endokrinines\/Cukrinis_diabetas\">cukrinis diabet<\/a>as, kuriuo sergant kraujyje yra per didel\u0117 gliukoz\u0117s koncentracija (hiperglikemija), galinti pa\u017eeisti arterijas. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Padid\u0117jusi bendrojo cholesterolio, ypa\u010d ma\u017eo tankio lipoprotein\u0173 \u2013 \u201eblogojo\u201c cholesterolio ir suma\u017e\u0117jusi didelio tankio lipoprotein\u0173 \u2013 \u201egerojo\u201c cholesterolio koncentracija kraujyje.<\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Antsvoris ir ma\u017eas fizinis aktyvumas. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Geriamieji kontraceptikai. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Vyri\u0161koji lytis. Manoma, kad moteri\u0161kieji hormonai estrogenai apsaugo kraujagysli\u0173 sienel\u0119. Ta\u010diau po <a href=\"http:\/\/www.sos03.lt\/Ligos\/Moters\/Menopauze\">menopauz\u0117s<\/a>, kai organizmas nebegamina estrogen\u0173, moterys pradeda spar\u010diai vytis vyrus sergamumu ateroskleroze. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l3 level1 lfo1; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Paveldimumas. Da\u017eniausiai greta paveldimumo b\u016bna bent keli anks\u010diau min\u0117ti rizikos veiksniai. <\/span><\/li>\n<\/ul>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Kaip pasirei\u0161kia <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">ateroskleroz\u0117<\/a><\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\"><a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">Ateroskleroz\u0117<\/a> pavojinga tuo, kad ligos prad\u017eioje \u017emogus da\u017eniausiai niekuo nesiskund\u017eia ir nejau\u010dia joki\u0173 ligos po\u017eymi\u0173. Daug met\u0173 aterosklerozin\u0117 plok\u0161tel\u0117 auga, nesukeldama joki\u0173 po\u017eymi\u0173. Ji pasirei\u0161kia netik\u0117tai, paprastai tada, kai yra jau gerokai \u012fsisen\u0117jusi, o arterij\u0173 spindis jau b\u016bna susiaur\u0117j\u0119s 50 proc. ir daugiau. D\u0117l to organai per ma\u017eai apr\u016bpinami krauju, vystosi \u0161i\u0173 organ\u0173 i\u0161emija. Kai kuriems \u017emon\u0117ms simptomai pasirei\u0161kia tik visi\u0161kai u\u017esikim\u0161us kraujagysl\u0117s spind\u017eiui, kada i\u0161tinka <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/miokardo-infarktas\/4345\">miokardo infarktas<\/a> arba insultas. Taigi simptomai priklauso nuo arterijos pa\u017eeidimo laipsnio ir nuo to, kuri k\u016bno dalis ar organas nepakankamai apr\u016bpinami krauju:<\/span><\/p>\n<ul style=\"margin-top: 0cm;\" type=\"disc\">\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Jei pa\u017eeistos \u0161irdies kraujagysl\u0117s, susergama i\u0161emine \u0161irdies liga. Da\u017eniausiai ji pasirei\u0161kia <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/krutines-angina\/4430\">kr\u016btin\u0117s angina<\/a> \u2013 staigiu trumpalaikiu maud\u017eian\u010dio pob\u016bd\u017eio skausmu u\u017e kr\u016btinkaulio ir kair\u0117je kr\u016btin\u0117s pus\u0117je, plintan\u010diu \u012f kair\u0119 rank\u0105, kakl\u0105, kuri gali praeiti pavartojus vaist\u0173. Progresuojant ligai gali trikti \u0161irdies ritmas, o visi\u0161kai sutrikus kraujotakai, kai aterosklerozin\u0117 plok\u0161tel\u0117 pilnai u\u017ekem\u0161a kraujagysl\u0117s spind\u012f, i\u0161tinka <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/miokardo-infarktas\/4345\">miokardo infarktas<\/a>. Tada skausmas u\u017e kr\u016btinkaulio u\u017esit\u0119sia, b\u016bna labai stiprus, nepraeina pavartojus nitroglicerino. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Esant galvos smegen\u0173 kraujagysli\u0173 pa\u017eeidimui, gali i\u0161tikti praeinantis smegen\u0173 i\u0161emijos priepuolis ar insultas, kuris pasirei\u0161kia k\u016bno dalies aptirpimu, silpnumu (iki visi\u0161ko paraly\u017eiaus), reg\u0117jimo, kalbos, rijimo, pusiausvyros sutrikimu, galvos svaigimu, trumpalaikiu s\u0105mon\u0117s praradimu.<\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Jei pa\u017eeistos koj\u0173 raumenis maitinan\u010dios arterijos, susergama periferini\u0173 arterij\u0173 liga. Da\u017enai pastaroji liga pasirei\u0161kia protarpiniu \u0161lubumu \u2013 fizinio kr\u016bvio metu atsirandan\u010diu \u0161laun\u0173 ar blauzdos raumen\u0173 skausmu, praeinan\u010diu sustojus ir pails\u0117jus. Progresuojant aterosklerozei gali i\u0161sivystyti arterij\u0173 <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/tromboze\/4331\">tromboz\u0117<\/a>, kai susidar\u0119s kre\u0161ulys visi\u0161kai u\u017ekem\u0161a spind\u012f. Pa\u017eeista gal\u016bn\u0117 tampa labai skausminga, nejudri, pab\u0105la, aptirpsta. U\u017esit\u0119sus kraujotakos sutrikimui ir laiku nesuteikus pagalbos, vystosi gal\u016bn\u0117s gangrena.<\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Inkst\u0173 arterij\u0173 <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">ateroskleroz\u0117<\/a> da\u017eniausiai pasirei\u0161kia gydymui vaistais atspariu staiga ir smarkiai padid\u0117jusiu kraujosp\u016bd\u017eiu \u2013 inkstine arterine hipertenzija. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l5 level1 lfo2; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Esant \u017earnyno arterij\u0173 aterosklerozei b\u016bdingi 20\u201330 min. po valgio atsirandantys pilvo skausmai, <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/viduriavimas-2\/72707\">viduriavimas<\/a> ar viduri\u0173 u\u017ekiet\u0117jimas, <a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/pilvo-putimas\/56475\">pilvo p\u016btimas<\/a>. I\u0161sivys\u010dius pa\u017eeistos \u017earnyno kraujagysl\u0117s trombozei i\u0161tinka \u017earnyno infarktas \u2013 atsiranda staigus a\u0161trus pilvo skausmas, didelis silpnumas, v\u0117mimas, tu\u0161tinimasis krauju.<\/span><\/li>\n<\/ul>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Visos min\u0117tos b\u016bkl\u0117s yra labai rimtos, kurioms atsiradus b\u016btina kreiptis \u012f gydytoj\u0105.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Ar yra veiksming\u0173 gydymo b\u016bd\u0173<\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\"><a href=\"https:\/\/pasveik.lt\/lt\/ligos-ir-sindromai\/ateroskleroze\/4332\">Ateroskleroz\u0117<\/a> \u2013 negr\u012f\u017etamas procesas, tod\u0117l taikomas kompleksinis gydymas tik sustabdo jos tolesn\u012f progresavim\u0105:<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l4 level1 lfo5;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">nemedikamentinis \u2013 gyvensenos korekcija;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l4 level1 lfo5;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">medikamentinis gretutini\u0173 lig\u0173 gydymas \u2013 reguliuojant kraujo spaudim\u0105, kre\u0161\u0117jim\u0105, cukraus, riebal\u0173 kiek\u012f kraujyje;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l4 level1 lfo5;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">chirurginis gydymas \u2013 operacijos metu kraujotaka atkuriama pa\u0161alinus pa\u017eeist\u0105 kraujagysl\u0117s dal\u012f. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Profilaktikos ir gydymo priemon\u0117s glaud\u017eiai tarpusavyje susijusios. Norint i\u0161vengti (ar bent jau sul\u0117tinti) ateroskleroz\u0117s vystym\u0105si ir pagerinti \u017emogaus gyvenimo kokyb\u0119, pirmiausia b\u016btina \u0161alinti kei\u010diamuosius rizikos veiksnius:<\/span><\/p>\n<ul style=\"margin-top: 0cm;\" type=\"disc\">\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Antsvorio gydymas. Visiems turintiems antsvorio \u017emon\u0117ms rekomenduojama siekti normalaus k\u016bno svorio. Ar turite antsvorio, paai\u0161k\u0117s apskai\u010diuojant <\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">KMI<\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\"> (k\u016bno mas\u0117s indeks\u0105) pagal formul\u0119: KMI = k\u016bno mas\u0117 (kg) \/ \u016bgis (m<sup>2<\/sup>). Normalus svoris, kai k\u016bno mas\u0117s indeksas 19\u201325. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Fizinio kr\u016bvio didinimas. Reikalinga reguliari fizin\u0117 veikla. Geriausi\u0173 rezultat\u0173 pasiekiama sportuojant reguliariai po pusvaland\u012f 3\u20134 kartus per savait\u0119. Fizin\u012f aktyvum\u0105 reikia didinti laipsni\u0161kai. Reik\u0117t\u0173 prad\u0117ti nuo komfortabilaus lygio ir pama\u017eu didinti trukm\u0119 bei intensyvum\u0105.<\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Subalansuota mityba. Ypa\u010d svarbu ma\u017einti cholesterolio kiek\u012f kraujyje. Reikia tinkamai maitintis, atsisakyti daug cholesterolio turin\u010di\u0173 maisto produkt\u0173. Patariama valgyti daug \u0161vie\u017ei\u0173 dar\u017eovi\u0173, vaisi\u0173, rupi\u0173 milt\u0173 ir nemalt\u0173 gr\u016bd\u0173 duonos gamini\u0173, javaini\u0173, ry\u017ei\u0173, ank\u0161tini\u0173, makaron\u0173, neriebi\u0173 pieno produkt\u0173, liesos m\u0117sos, pauk\u0161tienos be odel\u0117s, \u017euvies. Maist\u0105 virti ar tro\u0161kinti be riebal\u0173 arba gaminti garuose. Sviest\u0105 ir s\u016br\u012f keisti augalini\u0173 riebal\u0173 pagrindu pagamintais produktais. <\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Ner\u016bkyti. Tabako d\u016bmuose esantis nikotinas sutraukia periferines kraujagysles, da\u017enina puls\u0105 ir didina arterin\u012f kraujo spaudim\u0105, d\u0117l to padid\u0117ja pavojus susirgti ateroskleroze. Metus r\u016bkyti greitai pager\u0117ja savijauta, ma\u017e\u0117ja tikimyb\u0117 susirgti ateroskleroze ir kitomis ligomis. Mesti r\u016bkyti verta bet kuriuo am\u017eiaus laikotarpiu. Net metus gana v\u0117lyvame am\u017eiuje pailg\u0117ja gyvenimo trukm\u0117.<\/span><\/li>\n<li class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%; mso-list: l1 level1 lfo3; tab-stops: list 36.0pt;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Efektyviai koreguoti arterin\u0119 hipertenzij\u0105 ir gliukoz\u0117s kiek\u012f kraujyje sergant cukriniu diabetu. <\/span><\/li>\n<\/ul>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-style: italic;\">Omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 poveikis \u0161irdies ir kraujagysli\u0173 ligoms <\/span><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Kai kuri\u0173 \u0161ali\u0173 gyventojai, pavyzd\u017eiui, eskimai ir japonai \u0161ia liga serga kur kas re\u010diau, nes vartoja daug \u017euvies, kurioje yra omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173. Omega-3 riebal\u0173 r\u016bg\u0161tys nesigamina \u017emogaus organizme ir turi b\u016bti gaunamos su maistu.\u017duv\u0173 taukai \u2013 svarbiausias polineso\u010di\u0173j\u0173 riebal\u0173 r\u016bg\u0161\u010di\u0173 \u0161altinis<strong style=\"mso-bidi-font-weight: normal;\">. <\/strong>Juose yra ypating\u0173 polineso\u010di\u0173j\u0173 omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 \u2013 dokozaheksaeno (DHR) ir eikozapentaeno (EPR) bei vitamin\u0173 A ir D.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Klinikini\u0173 tyrim\u0173 duomenimis, taip pat \u012frodytas apsauginis omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 poveikis \u0161ird\u017eiai ir kraujagysl\u0117ms. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Nustatyta, kad omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 grupei priklausan\u010dios dokozaheksaeno bei eikozapentaeno r\u016bg\u0161tys:<\/span><\/em><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">gerina autonomin\u0117s nerv\u0173 sistemos funkcijas;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">slopina trombocit\u0173 agregacij\u0105;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">pasi\u017eymi vazodilatacin\u0117mis savyb\u0117mis;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">turi poveik\u012f aritmij\u0173 ma\u017einimui;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">ma\u017eina arterin\u012f kraujo spaudim\u0105;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">slopina u\u017edegim\u0105;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">gerina endotelio funkcijas;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">stabilizuoja kre\u0161ul\u012f;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">ma\u017eina ateroskleroz\u0117s vystym\u0105si;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">ma\u017eina laisv\u0173 riebal\u0173 r\u016bg\u0161\u010di\u0173 ir triglicerid\u0173 koncentracij\u0105;<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">reguliuoja adiponektino sintez\u0119; <\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 54.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l2 level1 lfo6;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Symbol; mso-fareast-font-family: Symbol; mso-bidi-font-family: Symbol;\"><span style=\"mso-list: Ignore;\">\u00b7<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">ma\u017eina kolageno sankaup\u0173\/nuos\u0117d\u0173 susidarym\u0105.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">2008\u00a0m. atlikt\u0173 trij\u0173 klinikini\u0173 tyrim\u0173 duomenimis, kuriuose dalyvavo 32\u00a0t\u016bkst. pacient\u0173, nustatyta, kad vartojusiems omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 (didinant j\u0173 kiek\u012f ar vartojant \u017euv\u0173 tauk\u0173 papildus) \u0161irdies ir kraujagysli\u0173 lig\u0173 komplikacij\u0173 tikimyb\u0117 suma\u017e\u0117jo nuo 19 iki 45\u00a0proc. Remiantis \u0161i\u0173 tyrim\u0173 duomenimis, rekomenduojama didinti tiek eikozapentaeno, tiek dokozaheksaeno r\u016bg\u0161ties kiek\u012f maiste, ypa\u010d turintiems \u0161irdies ir kraujagysli\u0173 rizikos veiksni\u0173 asmenims. Sergant \u0161iomis ligomis suvartojam\u0173 omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 kiekis tur\u0117t\u0173 b\u016bti apie 1\u00a0g\/d., o nesergantiems\u00a0\u2013 500\u00a0mg\/d. Pacientams, kuriems nustatyta hipertrigliceridemija, 3<\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: 'Times New Roman'; mso-bidi-font-family: Arial;\">\u2012<\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">4\u00a0g\/d. dokozaheksaeno ir eikozapentaeno r\u016bg\u0161ties triglicerid\u0173 kiek\u012f suma\u017eina 20<\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: 'Times New Roman'; mso-bidi-font-family: Arial;\">\u2012<\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">50\u00a0proc. Kompleksinis gydymas omega-3 riebal\u0173 r\u016bg\u0161timis ir statinais yra saugesnis ir efektyvesnis b\u016bdas suma\u017einti lipid\u0173 kiek\u012f kraujyje bei pagerinti \u0161irdies ir kraujagysli\u0173 lig\u0173 prognoz\u0119 nei gydymas vien statinais.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Atsitiktini\u0173 im\u010di\u0173 klinikiniame tyrime DART (angl. <em>diet and reinfarction trial<\/em>) dalyvavo 2\u00a0033 pacientai, sirg\u0119 miokardo infarktu. Jiems buvo rekomenduota dieta, koreguojant tris veiksnius: ma\u017einant suvartojam\u0173 riebal\u0173 kiek\u012f, didinant polineso\u010di\u0173j\u0173 ir so\u010di\u0173j\u0173 riebal\u0173 r\u016bg\u0161\u010di\u0173 santyk\u012f, didinant \u017euvies, gr\u016bdini\u0173 kult\u016br\u0173 kiek\u012f maiste. Mir\u0161tamumas tarp pacient\u0173, kurie \u0117m\u0117 vartoti daugiau \u017euvies, per 2 metus suma\u017e\u0117jo 29\u00a0proc. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong style=\"mso-bidi-font-weight: normal;\"><em><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 dozavimas<\/span><\/em><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l0 level1 lfo4; tab-stops: list 0cm;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New'; mso-bidi-font-weight: bold;\"><span style=\"mso-list: Ignore;\">o<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Be gydytojo prie\u017ei\u016bros rekomenduojama suvartoti iki 3\u00a0g\/d. omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173, nes, didinant j\u0173 doz\u0119, did\u0117ja kraujavimo rizika d\u0117l arachidono r\u016b\u0161ties metabolizmo slopinimo. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l0 level1 lfo4; tab-stops: list 0cm;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New'; mso-bidi-font-weight: bold;\"><span style=\"mso-list: Ignore;\">o<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Sveikiems asmenims, nesirgusiems \u0161irdies ir kraujagysli\u0173 ligomis, Amerikos \u0161irdies asociacija rekomenduoja valgyti \u017euvies ne ma\u017eiau kaip du kartus per savait\u0119. Did\u017eiausias eikozapentaeno ir dokozaheksaeno r\u016bg\u0161ties kiekis nat\u016braliai randamas riebiose j\u016brin\u0117se \u017euvyse \u2013 skumbr\u0117se, la\u0161i\u0161ose, otuose, sardin\u0117se, silk\u0117se.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l0 level1 lfo4; tab-stops: list 0cm;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New'; mso-bidi-font-weight: bold;\"><span style=\"mso-list: Ignore;\">o<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial; mso-bidi-font-weight: bold;\">Pacientams, kuriems nustatyta \u0161irdies ir kraujagysli\u0173 liga, rekomenduojama suvartoti 1000\u00a0mg\/d. eikozapentaeno ir dokozaheksaeno r\u016bg\u0161ties. Efektas pastebimas po dviej\u0173 trij\u0173 savai\u010di\u0173.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"margin-left: 36.0pt; text-align: justify; text-indent: -18.0pt; line-height: 150%; mso-list: l0 level1 lfo4; tab-stops: list 0cm;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: 'Courier New'; mso-fareast-font-family: 'Courier New'; mso-bidi-font-weight: bold;\"><span style=\"mso-list: Ignore;\">o<span style=\"font: 7.0pt 'Times New Roman';\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <\/span><\/span><\/span><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Yra mokslini\u0173 tyrim\u0173, \u012frodan\u010di\u0173, jog vartojant po 1\u20132 gramus per dien\u0105 omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173, ma\u017e\u0117ja ne tik i\u0161emin\u0117s \u0161irdies ligos, bet ir insulto rizika. <\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><strong><em style=\"mso-bidi-font-style: normal;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">\u201eM\u00f6ller\u2019s\u201c rekomendacija \u2013 1000 mg omega-3 per par\u0105<\/span><\/em><\/strong><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Vertingiausios i\u0161 omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 \u017emogaus organizmui yra \u017euvin\u0117s kilm\u0117s eikozapentaeno (EPR) ir dokozaheksaeno (DHR) r\u016bg\u0161tys. Tod\u0117l verta atkreipti d\u0117mes\u012f \u012f \u0161i\u0173 riebal\u0173 r\u016bg\u0161\u010di\u0173 koncentracij\u0105 produktuose. Norvegijos sveikatos prie\u017ei\u016bros specialistai rekomenduoja kasdien suvartoti 1000\u20132000 miligram\u0173 omega-3. Mokslini\u0173 tyrim\u0173 duomenimis, 1000 miligram\u0173 \u017euvin\u0117s kilm\u0117s omega-3 u\u017etikrina teigiam\u0105 poveik\u012f sveikatai. Arbatiniame \u0161auk\u0161telyje (5 ml) \u201eM\u00f6ller\u2019s\u201c skyst\u0173 \u017euv\u0173 tauk\u0173 yra 1200 miligram\u0173 \u017euvin\u0117s kilm\u0117s omega-3. Tod\u0117l garantuojama, kad \u201eM\u00f6ller\u2019s\u201c skysti \u017euv\u0173 taukai suteiks visk\u0105, kas yra rekomenduojama Norvegijos sveikatos prie\u017ei\u016bros specialist\u0173 ir yra \u012frodyta mokslo.<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">Dabar Lietuvos vaistin\u0117se galima \u012fsigyti naujausi\u0105 <em>M\u00f6ller\u2019s<\/em> produkt\u0105 \u2013 skystus \u017euv\u0173 taukus <em>M\u00f6ller\u2019s<\/em> <em style=\"mso-bidi-font-style: normal;\">Omega-3<\/em> <em style=\"mso-bidi-font-style: normal;\">Premium<\/em>. \u0160is preparatas \u017euv\u0173 tauk\u0173 produkt\u0173 portfelyje yra i\u0161skirtinis. D\u0117l itin didel\u0117s omega-3 koncentracijos lygi\u0173 produkt\u0173 sunku rasti \u2013 viename arbatiniame \u0161auk\u0161telyje yra ypa\u010d daug \u2013 net 1780 mg \u2013 verting\u0173j\u0173 omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173!<\/span><\/p>\n<p class=\"MsoNormal\" style=\"text-align: justify; line-height: 150%;\"><span style=\"font-size: 10.0pt; line-height: 150%; font-family: Arial;\">\u017durnalas Farmacija ir laikas <br \/><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p><!--[if gte mso 9]><xml>\n <o:OfficeDocumentSettings>\n  <o:AllowPNG\/>\n  <o:TargetScreenSize>1024x768<\/o:TargetScreenSize>\n <\/o:OfficeDocumentSettings>\n<\/xml><![endif]--><\/p>\n<p style=\"text-align: justify;\"><!--[if gte mso 9]><xml>\n <w:WordDocument>\n  <w:View>Normal<\/w:View>\n  <w:Zoom>0<\/w:Zoom>\n  <w:HyphenationZone>19<\/w:HyphenationZone>\n  <w:Compatibility>\n   <w:BreakWrappedTables\/>\n   <w:SnapToGridInCell\/>\n   <w:WrapTextWithPunct\/>\n   <w:UseAsianBreakRules\/>\n  <\/w:Compatibility>\n <\/w:WordDocument>\n<\/xml><![endif]--><!--[if gte mso 10]>\n\n\n<style>\n \/* Style Definitions *\/\n table.MsoNormalTable\n\t{mso-style-name:\"Table Normal\";\n\tmso-tstyle-rowband-size:0;\n\tmso-tstyle-colband-size:0;\n\tmso-style-noshow:yes;\n\tmso-style-parent:\"\";\n\tmso-padding-alt:0cm 5.4pt 0cm 5.4pt;\n\tmso-para-margin:0cm;\n\tmso-para-margin-bottom:.0001pt;\n\tmso-pagination:widow-orphan;\n\tfont-size:10.0pt;\n\tfont-family:\"Times New Roman\";}\n<\/style>\n\n\n<![endif]--><span style=\"font-size: 10.0pt; line-height: 115%; font-family: Arial; mso-fareast-font-family: Calibri; mso-ansi-language: LT; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;\">Vertingiausios i\u0161 omega-3 riebal\u0173 r\u016bg\u0161\u010di\u0173 \u017emogaus organizmui yra \u017euvin\u0117s kilm\u0117s eikozapentaeno (EPR) ir dokozaheksaeno (DHR) r\u016bg\u0161tys. Tod\u0117l verta atkreipti d\u0117mes\u012f \u012f \u0161i\u0173 riebal\u0173 r\u016bg\u0161\u010di\u0173 koncentracij\u0105 produktuose. Norvegijos sveikatos prie\u017ei\u016bros specialistai rekomenduoja kasdien suvartoti 1000\u20132000 miligram\u0173 omega-3. Mokslini\u0173 tyrim\u0173 duomenimis, 1000 miligram\u0173 \u017euvin\u0117s kilm\u0117s omega-3 u\u017etikrina teigiam\u0105 poveik\u012f sveikatai. <\/span><\/p>\n","protected":false},"author":1,"featured_media":8347,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[27313],"tags":[1008,76,400,39,93,141,711,184,791,947,157,49,710,752,125,48],"site":[],"post_item_type":[27345],"class_list":["post-8346","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gydymo-naujienos","tag-arterijos","tag-ateroskleroze","tag-diabetas","tag-dieta","tag-infarktas","tag-insultas","tag-kraujagysles","tag-maiste","tag-mases","tag-moller","tag-nutukimas","tag-omega","tag-ploksteles","tag-progresuojant","tag-rukymas","tag-taukai"],"acf":{"post_sites":false},"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/8346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/comments?post=8346"}],"version-history":[{"count":0,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/posts\/8346\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media\/8347"}],"wp:attachment":[{"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/media?parent=8346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/categories?post=8346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/tags?post=8346"},{"taxonomy":"site","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/site?post=8346"},{"taxonomy":"post_item_type","embeddable":true,"href":"https:\/\/www.pasveik.lt\/lt\/wp-json\/wp\/v2\/post_item_type?post=8346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}